GtoPdb Ligand ID: 7437

Synonyms: Entyvio® | LDP-02 | LDP02 | MLN-0002 | MLN-002 | MLN002
vedolizumab is an approved drug (FDA and EMA (2014))
Compound class: Antibody
Comment: The peptide sequences for the heavy and light chains that form this antibody are annotated in its IMGT/mAb-DB record.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: vedolizumab

Compound class Antibody
Approved drug? Yes (FDA and EMA (2014))
International Nonproprietary Names
INN number INN
9093 vedolizumab
Entyvio® | LDP-02 | LDP02 | MLN-0002 | MLN-002 | MLN002
Database Links
Specialist databases
IMGT/mAb-DB 300
Other databases
GtoPdb PubChem SID 178104009
PubChem SID 178104009
Search PubMed clinical trials vedolizumab
Search PubMed titles vedolizumab
Search PubMed titles/abstracts vedolizumab
Wikipedia Vedolizumab